Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

General Mills Recalls Refrigerated Pillsbury Cinnamon Rolls With Icing

RELATED NEWS
Trade GIS now with 

Food products company General Mills Inc. (GIS: Quote) said Friday it is recalling a limited quantity of refrigerated Pillsbury Cinnamon Rolls with Icing. The action is being taken as a precaution because the dough may contain fragments from a broken piece of plastic on the production line, the company said. No other Pillsbury dough products are being recalled.

Only specific 8-count single and double packages with certain date codes of Pillsbury Cinnamon Rolls with Icing are being recalled. These include

- Pillsbury Cinnamon Rolls with Icing that have use-by-dates of 30, 31 October 2013.

- Pillsbury Cinnamon Rolls with Icing 2-pack that have use-by-dates of 18, 26, 31 October 2013. The products are sold in grocery stores nationally.

No other flavors or varieties of Pillsbury Cinnamon Rolls or Pillsbury dough products are being recalled. Pillsbury Flaky Cinnamon Rolls and Pillsbury Grands! Cinnamon Rolls are not included in the recall.

Shares of General Mills are trading at $49.35, up $0.25 or 0.51%, on a volume of 1.6 million shares on the NYSE.

Click here to receive FREE breaking news email alerts for General Mills and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Proctor and Gamble (PG) has sold two of its soap brands to European consumer products giant Unilever (UN). Cincinnati-based P&G says the sale includes the global Camay brand, the Zest brand outside of North America and its Talisman manufacturing plant in Mexico. The plant employs approximately... Dish Network is no longer carrying Fox News in yet another dispute for the television provider. Fox News, which changed the face of cable news with its ardent advocacy of conservative issues, went dark Sunday, replaced on Dish by The Blaze, Glen Beck's new right-leaning channel. Fox Business channel... Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.